siRNA, Anti-Human ABL1, LNA(CAT#: SIRGT04016WQ-LNA)

The product SIRGT04016WQ-LNA is a type of small interfering RNA (siRNA) that targets ABL1 gene and regulates the expression of gene. The siRNA interferes with the expression of ABL1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_005157.5; NM_007313.2
Alternative Names ABL; CHDSKM; JTK7; bcr/abl; c-ABL; c-ABL1; p150; v-abl
Related Diseases Leukemia, Skeletal Malformations Syndrome
Purification HPLC
Target Gene
Gene ID 25
Uniprot ID P00519

Related Products